Steroid receptor status, proliferation and metallothionein expression in primary invasive ductal breast cancers

Pathology and Oncology Research

Volumn 10, Issue 4, 2004, Pages 207-211

  Surowiak, Pawe ^a,b   Paluchowski, Piotr ^c   Wysocka, Teresa ^a   Wojnar, Andrzej ^c   Zabel, Maciej ^a,d  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Lower Silesia Center of Oncology   (Poland)

^c Klinikum Pinneberg   (Germany)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Breast cancer; Hormone receptor status; Ki 67; Metallothionein

Indexed keywords

ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; METALLOTHIONEIN; MONOCLONAL ANTIBODY; PARAFFIN; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; SILVER STAINING; STATISTICAL ANALYSIS;

EID: 12344327337     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033762     Document Type: Article

References (20)

1. Biesterfeld S, Farokhzad F, Klueppel D, et al: Improvement of breast cancer prognostication using cell kinetic-based silver-stainable nucleolar organizer region quantification of the MIB-1 positive tumor cell compartment. Virchows Arch 438: 478-484, 2001
2. Clahsen PC, Van de Velde CJH, Duval C, et al: The utility of mitotic index, oestrogen receptor and Ki67 measurements in the creation of novel prognostic indices for node-negative breast cancer. Eur J Surg Oncol 25: 356-363, 1999
3. Detreb S, King N, Salter J, et al: Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer. J Clin Pathol 47: 240-244, 1994
4. Fitzgibbons PL, Page DL, Weaver D, et al: Prognostic factors in breast cancer. College of American Pathologist consensus statement 1999. Arch Pathol Lab Med 124: 966-978, 2000
5. Friedline JA, Garret SH, Somji S, et al: Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines. Am J Pathol 152: 23-27, 1998
6. Harris H, Henderson RA, Bhat RA, Komm BS: Regulation of metallothionein II messenger ribonucleic acid measures exogenous estrogen receptor beta activity in SAOS-2 and LNCaPLN3 cells. Endocrinology 142: 645-652, 2001
7. Hishikawa Y, Koji T, Dhar DK, et al: Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus. Br J Cancer 81: 712-720, 1999
8. Ioachim E, Assimakopoulos D, Peschos D, et al: Immunohistochemical expression of metallothionein in benign, premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen. Pathol Res Pract 195: 809-814, 1999
9. Jensen EV, Cheng G, Palimieri C, et al: Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98: 15197-15202, 2001
10. Jin R, Bay BH, Chow VT, Tan PH: Metallothionein IF mRNA expression correlates with histological grade in breast carcinoma. Breast Cancer Res Treat 66: 265-272, 2001
11. Jin R, Chow VT, Tan PH, et al: Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23: 81-86, 2002
12. Kagi JHR: Overview of metallothionein. Methods Enzymol 205: 613-626, 1991
13. Keshigan AA, Cnaan A: Estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Poor clinical outcome. Arch Pathol Lab Med 120: 970-973, 1996
14. Ploton D, Menager M, Jeannesson P, et al: Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 18: 5-14, 1986
15. Remmele W, Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987
16. Schmidt CJ, Hamer DH: Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 83: 3346-3350, 1986
17. Schwint A, Folco A, Morales A, et al: AgNOR mark epithelial foci in malignant transformation in hamster cheek pouch carcinogenesis. J Oral Pathol Med 25: 20-24, 1996
18. Surowiak P, Dziźgiel P, Zabel M, et al: Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma. Fol Histochem Cytobiol 39: 145-146, 2001
19. Zas awski R, Surowiak P, Dziȩgiel P, et al: Analysis of the expression of estrogen and progesterone receptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relation to the phase of the menstrual cycle. Med Sci Monit 7: 784-789, 2001
20. Zhang R, Zhang H, Wei H, Luo X: Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J Environ Pathol Toxicol Oncol 19: 95-97, 2000